跳至主要内容
临床试验/NL-OMON20043
NL-OMON20043已完成不适用

A randomised, double-blind, placebo-controlled study to evaluate the efficacy of imiquimod 5% in women with Vulvar Intraepithelial Neoplasia (VIN) 2 and 3.

niversity and governmental budget (90%), and a small unrestricted research grand from 3M Nederland (10%) and studymedication with randomizationcode.0 个研究点目标入组 52 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
52